Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_assertion type Assertion NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_head.
- NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_assertion description "[Nonclassic adrenal hyperplasia should be excluded in all women presenting with hirsutism, with use of a basal follicular phase 17-hydroxyprogesterone level, regardless of the presence of polycystic ovaries or metabolic dysfunction; however, women with nonclassic adrenal hyperplasia have a higher prevalence of normal ovulation and lower likelihood of having an LH/FSH ratio >2 or polycystic ovaries.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_provenance.
- NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_assertion evidence source_evidence_literature NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_provenance.
- NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_assertion SIO_000772 19726039 NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_provenance.
- NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_assertion wasDerivedFrom befree-2016 NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_provenance.
- NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_assertion wasGeneratedBy ECO_0000203 NP760872.RAAbBNU2vj_PHqPP8M7e6DEyZ8YwRH57DRnkpyR5aljlY130_provenance.